Xanthine amine congener |
96865-92-8 |
XAC |
Papaxac |
N-(2-aminoethyl)-2-4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxyacetamide |
CHEMBL273094 |
8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine |
n-(2-aminoethyl)-2-4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1h-purin-8-yl)phenoxyacetamide |
Xanthine amine congener xac |
8-4-(2-Aminoethyl)aminocarbonylmethyloxyphenyl-1,3-dipropylxanthine |
N-(2-aminoethyl)-2-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenoxy)acetamide |
3Hxanthine amine congener |
3HXAC |
Lopac-X-103 |
8-(4-(((2-(4-Aminophenylacetylamino)ethyl)carbonyl)methyl)oxy)phenyl-1,3-dipropylxanthine |
Lopac0_001279 |
GTPL404 |
GTPL432 |
SCHEMBL1000686 |
DTXSID10242595 |
Xanthine amine congener pound>>XAC |
ZINC9210767 |
BDBM50207816 |
PDSP1_000319 |
PDSP1_000445 |
PDSP2_000317 |
PDSP2_000443 |
CCG-205352 |
LP01279 |
SDCCGSBI-0051245.P002 |
NCGC00016097-01 |
NCGC00016097-02 |
NCGC00016097-03 |
NCGC00016097-04 |
NCGC00094514-01 |
NCGC00094514-02 |
Xanthine amine congener, >=96% (HPLC) |
EU-0101279 |
X-103 |
L000963 |
SR-01000075243 |
SR-01000075243-1 |
Q27089239 |
3,7-diethyl-9-(4-(N-2-aminoethylcarboxamidomethoxy))phenylxanthine |
Xanthine, 8-4-(2-aminoethyl)aminocarbonylmethoxyphenyl-1,3-dipropyl |
Acetamide, N-(2-aminoethyl)-2-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy)- |
N-(2-Amino-ethyl)-2-4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-phenoxy-acetamide |
N-(2-Amino-ethyl)-2-4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-phenoxy-acetamide (xanthine amine congenere, XAC) |
N-(2-Amino-ethyl)-2-4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-phenoxy-acetamide(XAC) |
N-(2-Amino-ethyl)-2-4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)-phenoxy-acetamide |
N-(2-Aminoethyl)-2-4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy-acetamide hydrochloride |
N-(2-Aminoethyl)-2-4-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)phenoxyacetamide # |